Alexis Moe
Nurse Practitioner · Bismarck, NDNPI 1639815228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations.
Across 90 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$144
- Amgen$136
- Travere Therapeutics, Inc.$136
- Calliditas Therapeutics US Inc.$127
- Dexcom, Inc.$112
- Boehringer Ingelheim$103
- plus $732 from 23 others
What the payments were for
- Food & beverage$1,489100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $144 |
| Amgen | 9 | $136 |
| Travere Therapeutics, Inc. | 7 | $136 |
| Calliditas Therapeutics US Inc. | 7 | $127 |
| Dexcom, Inc. | 6 | $112 |
| Boehringer Ingelheim | 7 | $103 |
| Lilly USA, LLC | 6 | $97 |
| Bayer | 6 | $92 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Novo Nordisk | 3 | $48 |
| Lexicon Pharmaceuticals, Inc. | 3 | $43 |
| AbbVie | 3 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Chiesi USA, Inc. | 1 | $29 |
| Exact Sciences | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 2 | $28 |
| Novartis | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
| Vifor Pharma, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
| Axsome Therapeutics, Inc. | 1 | $11 |
How this compares
$1,489 in reported general payments places this provider in the 85th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 18 | $2,965 |
| Potassium Citrate ErPotassium Citrate | 18 | $2,437 |
| Losartan Potassium | 52 | $579 |
| Spironolactone | 12 | $340 |
| Potassium Chloride | 12 | $237 |
| Amlodipine Besylate | 46 | $193 |
| Furosemide | 24 | $187 |
| Carvedilol | 13 | $182 |
| Omeprazole | 12 | $88 |
| Prednisone | 11 | $84 |
| Hydrochlorothiazide | 13 | $77 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Bismarck
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
- Cassie HoltBismarck$5K
- Katherine CarvellBismarck$5K
- Shih Ru MartinBismarck$5K
- Janel OlsonBismarck$4K
- Mallorie EmoryBismarck$3K
- Kayla CoferBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.